 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
Endocare has unveiled the next generation of our cryotherapy technology, the Cryocare CS. This system is fully integrated and provides planning, placement and treatment options to simplify our FDA-cleared Targeted CryoAblation of the Prostate (TCAP) procedure.
It consists of the AutoFreeze, a computer-controlled automated freezing mechanism that utilizes optimal power settings based upon target endpoint temperatures and continual feedback from the thermocouple tips. Along with AutoFreeze, Cryocare CS includes new Integrated Ultrasound technology that provides internal visualization of the prostate gland and patented CryoGuide planning software that assists physicians in determining optimal treatment of the entire gland as well as targeting specific cancerous areas of the prostate. The Cryocare CS also includes a new Urethral Warmer along with the highly successful vacuum-insulated Direct Access CryoProbes and CryoGrid, a brachytherapy-like grid fixed to the ultrasound stepped.
We believe that the Cryocare CS is the most sophisticated cryotherapy system currently available and it brings a new level of safety, ease of use and reproducibility to the use of cryotherapy in the treatment of prostate cancer.
© 2003-2004 Endocare, Inc. All rights reserved.
Endocare, Inc. supports